HomeBUSINESS
BUSINESS

Avastin Top-Seller in Japan for 2nd Straight Month in September: Encise Snapshot
(Oct.11.2018)

Chugai Pharmaceutical’s cancer drug Avastin (bevacizumab) retained its spot as the best-selling medicine in Japan in September, ringing up sales of 9 billion yen on an NHI price basis, according to a monthly snapshot report released by market research firm Encise ...
(LOG IN FOR FULL STORY)